R&D Areas of Focus
Allergan is committed to identifying and developing innovative treatments across its seven therapeutic categories that can help patients live longer, healthier lives.
Open Science
Allergan has sought to follow a different R&D path. We embrace an Open Science model that defines the Company’s position.
Our Pipeline
Allergan has an Open Science pipeline powered by 65+ programs in development.